Health
Moderna COVID-19 vaccine successful against emerging variants – European Pharmaceutical Review
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Posted: 27 January 2021 | Victoria Rees (European Pharmaceutical Review) | No comments yet
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Moderna has announced results from in vitro neutralisation studies of sera from individuals vaccinated with the company’s COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2.
According to the company, vaccination with the Moderna COVID-19 vaccine…
-
General19 hours agoRestaurants on the brink as business failures plateau
-
General8 hours agoThree maps that show the scale of the NSW flood disaster
-
General23 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General19 hours agoRegional house price growth outstrips capital cities